IDEAS home Printed from https://ideas.repec.org/a/nat/natcom/v13y2022i1d10.1038_s41467-022-30879-3.html
   My bibliography  Save this article

Leukocyte cell-derived chemotaxin 2 is an antiviral regulator acting through the proto-oncogene MET

Author

Listed:
  • Takayoshi Shirasaki

    (Kanazawa University Graduate School of Medical Science
    The University of North Carolina at Chapel Hill)

  • Satoshi Yamagoe

    (National Institute of Infectious Diseases)

  • Tetsuro Shimakami

    (Kanazawa University Graduate School of Medical Sciences)

  • Kazuhisa Murai

    (Kanazawa University Graduate School of Medical Science)

  • Ryu Imamura

    (Kanazawa University
    Kanazawa University)

  • Kiyo-Aki Ishii

    (Kanazawa University Graduate School of Medical Sciences)

  • Hiroaki Takayama

    (Kanazawa University Graduate School of Medical Sciences)

  • Yukako Matsumoto

    (Kanazawa University Graduate School of Medical Sciences)

  • Natsumi Tajima-Shirasaki

    (Kanazawa University Graduate School of Medical Sciences)

  • Naoto Nagata

    (Kanazawa University Graduate School of Medical Science)

  • Ryogo Shimizu

    (Kanazawa University Graduate School of Medical Science)

  • Souma Yamanaka

    (Kanazawa University Graduate School of Medical Science)

  • Atsushi Abe

    (Kanazawa University Graduate School of Medical Science)

  • Hitoshi Omura

    (Kanazawa University Graduate School of Medical Sciences)

  • Kazunori Kawaguchi

    (Kanazawa University Graduate School of Medical Sciences)

  • Hikari Okada

    (Kanazawa University Graduate School of Medical Sciences)

  • Taro Yamashita

    (Kanazawa University Graduate School of Medical Sciences)

  • Tomoki Yoshikawa

    (National Institute of Infectious Diseases)

  • Kazuhiro Takimoto

    (National Institute of Infectious Diseases)

  • Motoko Taharaguchi

    (National Institute of Infectious Diseases)

  • Shogo Takatsuka

    (National Institute of Infectious Diseases)

  • Yoshitsugu Miyazaki

    (National Institute of Infectious Diseases)

  • Toshikatsu Tamai

    (Kanazawa University Graduate School of Medical Science)

  • Yamato Tanabe

    (Kanazawa University Graduate School of Medical Science)

  • Makoto Kurachi

    (Kanazawa University Graduate School of Medical Science)

  • Yasuhiko Yamamoto

    (Kanazawa University Graduate School of Medical Science)

  • Shuichi Kaneko

    (Kanazawa University Graduate School of Medical Sciences)

  • Kunio Matsumoto

    (Kanazawa University
    Kanazawa University
    Kanazawa University)

  • Toshinari Takamura

    (Kanazawa University Graduate School of Medical Sciences)

  • Masao Honda

    (Kanazawa University Graduate School of Medical Science
    Kanazawa University Graduate School of Medical Sciences)

Abstract

Retinoic acid-inducible gene (RIG)-I is an essential innate immune sensor that recognises pathogen RNAs and induces interferon (IFN) production. However, little is known about how host proteins regulate RIG-I activation. Here, we show that leukocyte cell-derived chemotaxin 2 (LECT2), a hepatokine and ligand of the MET receptor tyrosine kinase is an antiviral regulator that promotes the RIG-I-mediated innate immune response. Upon binding to MET, LECT2 induces the recruitment of the phosphatase PTP4A1 to MET and facilitates the dissociation and dephosphorylation of phosphorylated SHP2 from MET, thereby protecting RIG-I from SHP2/c-Cbl-mediated degradation. In vivo, LECT2 overexpression enhances RIG-I-dependent IFN production and inhibits lymphocytic choriomeningitis virus (LCMV) replication in the liver, whereas these changes are reversed in LECT2 knockout mice. Forced suppression of MET abolishes IFN production and antiviral activity in vitro and in vivo. Interestingly, hepatocyte growth factor (HGF), an original MET ligand, inhibits LECT2-mediated anti-viral signalling; conversely, LECT2-MET signalling competes with HGF-MET signalling. Our findings reveal previously unrecognized crosstalk between MET-mediated proliferation and innate immunity and suggest that targeting LECT2 may have therapeutic value in infectious diseases and cancer.

Suggested Citation

  • Takayoshi Shirasaki & Satoshi Yamagoe & Tetsuro Shimakami & Kazuhisa Murai & Ryu Imamura & Kiyo-Aki Ishii & Hiroaki Takayama & Yukako Matsumoto & Natsumi Tajima-Shirasaki & Naoto Nagata & Ryogo Shimiz, 2022. "Leukocyte cell-derived chemotaxin 2 is an antiviral regulator acting through the proto-oncogene MET," Nature Communications, Nature, vol. 13(1), pages 1-15, December.
  • Handle: RePEc:nat:natcom:v:13:y:2022:i:1:d:10.1038_s41467-022-30879-3
    DOI: 10.1038/s41467-022-30879-3
    as

    Download full text from publisher

    File URL: https://www.nature.com/articles/s41467-022-30879-3
    File Function: Abstract
    Download Restriction: no

    File URL: https://libkey.io/10.1038/s41467-022-30879-3?utm_source=ideas
    LibKey link: if access is restricted and if your library uses this service, LibKey will redirect you to where you can use your library subscription to access this item
    ---><---

    References listed on IDEAS

    as
    1. Ying-Nan P. Chen & Matthew J. LaMarche & Ho Man Chan & Peter Fekkes & Jorge Garcia-Fortanet & Michael G. Acker & Brandon Antonakos & Christine Hiu-Tung Chen & Zhouliang Chen & Vesselina G. Cooke & Jas, 2016. "Allosteric inhibition of SHP2 phosphatase inhibits cancers driven by receptor tyrosine kinases," Nature, Nature, vol. 535(7610), pages 148-152, July.
    2. Yang Zhao & Xiang Ye & William Dunker & Yu Song & John Karijolich, 2018. "RIG-I like receptor sensing of host RNAs facilitates the cell-intrinsic immune response to KSHV infection," Nature Communications, Nature, vol. 9(1), pages 1-14, December.
    Full references (including those not matched with items on IDEAS)

    Most related items

    These are the items that most often cite the same works as this one and are cited by the same works as this one.
    1. Peter G. Miller & Murugappan Sathappa & Jamie A. Moroco & Wei Jiang & Yue Qian & Sumaiya Iqbal & Qi Guo & Andrew O. Giacomelli & Subrata Shaw & Camille Vernier & Besnik Bajrami & Xiaoping Yang & Ceris, 2022. "Allosteric inhibition of PPM1D serine/threonine phosphatase via an altered conformational state," Nature Communications, Nature, vol. 13(1), pages 1-16, December.
    2. Zhiyong Xu & Chunyi Guo & Qiaoli Ye & Yueli Shi & Yihui Sun & Jie Zhang & Jiaqi Huang & Yizhou Huang & Chunlai Zeng & Xue Zhang & Yuehai Ke & Hongqiang Cheng, 2021. "Endothelial deletion of SHP2 suppresses tumor angiogenesis and promotes vascular normalization," Nature Communications, Nature, vol. 12(1), pages 1-15, December.
    3. Suba Rajendren & Xiang Ye & William Dunker & Antiana Richardson & John Karijolich, 2023. "The cellular and KSHV A-to-I RNA editome in primary effusion lymphoma and its role in the viral lifecycle," Nature Communications, Nature, vol. 14(1), pages 1-15, December.
    4. Shiyun Cao & Shoukai Kang & Haibin Mao & Jiayu Yao & Liangcai Gu & Ning Zheng, 2022. "Defining molecular glues with a dual-nanobody cannabidiol sensor," Nature Communications, Nature, vol. 13(1), pages 1-14, December.
    5. Tanaz Sharifnia & Mathias J. Wawer & Amy Goodale & Yenarae Lee & Mariya Kazachkova & Joshua M. Dempster & Sandrine Muller & Joan Levy & Daniel M. Freed & Josh Sommer & Jérémie Kalfon & Francisca Vazqu, 2023. "Mapping the landscape of genetic dependencies in chordoma," Nature Communications, Nature, vol. 14(1), pages 1-17, December.
    6. Teklab Gebregiworgis & Yoshihito Kano & Jonathan St-Germain & Nikolina Radulovich & Molly L. Udaskin & Ahmet Mentes & Richard Huang & Betty P. K. Poon & Wenguang He & Ivette Valencia-Sama & Claire M. , 2021. "The Q61H mutation decouples KRAS from upstream regulation and renders cancer cells resistant to SHP2 inhibitors," Nature Communications, Nature, vol. 12(1), pages 1-15, December.
    7. Fenli Shao & Qianqian Liu & Yuyu Zhu & Zhidan Fan & Wenjun Chen & Shijia Liu & Xiaohui Li & Wenjie Guo & Gen-Sheng Feng & Haiguo Yu & Qiang Xu & Yang Sun, 2021. "Targeting chondrocytes for arresting bony fusion in ankylosing spondylitis," Nature Communications, Nature, vol. 12(1), pages 1-14, December.
    8. Surbhi Chouhan & Dhivya Sridaran & Cody Weimholt & Jingqin Luo & Tiandao Li & Myles C. Hodgson & Luana N. Santos & Samantha Sommer & Bin Fang & John M. Koomen & Markus Seeliger & Cheng-Kui Qu & Armell, 2024. "SHP2 as a primordial epigenetic enzyme expunges histone H3 pTyr-54 to amend androgen receptor homeostasis," Nature Communications, Nature, vol. 15(1), pages 1-19, December.

    More about this item

    Statistics

    Access and download statistics

    Corrections

    All material on this site has been provided by the respective publishers and authors. You can help correct errors and omissions. When requesting a correction, please mention this item's handle: RePEc:nat:natcom:v:13:y:2022:i:1:d:10.1038_s41467-022-30879-3. See general information about how to correct material in RePEc.

    If you have authored this item and are not yet registered with RePEc, we encourage you to do it here. This allows to link your profile to this item. It also allows you to accept potential citations to this item that we are uncertain about.

    If CitEc recognized a bibliographic reference but did not link an item in RePEc to it, you can help with this form .

    If you know of missing items citing this one, you can help us creating those links by adding the relevant references in the same way as above, for each refering item. If you are a registered author of this item, you may also want to check the "citations" tab in your RePEc Author Service profile, as there may be some citations waiting for confirmation.

    For technical questions regarding this item, or to correct its authors, title, abstract, bibliographic or download information, contact: Sonal Shukla or Springer Nature Abstracting and Indexing (email available below). General contact details of provider: http://www.nature.com .

    Please note that corrections may take a couple of weeks to filter through the various RePEc services.

    IDEAS is a RePEc service. RePEc uses bibliographic data supplied by the respective publishers.